Cita APA (7a ed.)
Burgard, C., Hein, C., Blickle, A., Bartholomä, M., Maus, S., Petto, S., . . . Rosar, F. (2024). Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: Monocentric evaluation of a prospective registry. European Journal of Nuclear Medicine & Molecular Imaging, 51(3), 885-896.
Cita Chicago Style (17a ed.)
Burgard, Caroline, Connor Hein, Arne Blickle, Mark Bartholomä, Stephan Maus, Sven Petto, Andrea Schaefer-Schuler, Samer Ezziddin, y Florian Rosar. "Change in Total Lesion PSMA (TLP) During [177Lu]Lu-PSMA-617 Radioligand Therapy Predicts Overall Survival in Patients with MCRPC: Monocentric Evaluation of a Prospective Registry." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 3 (2024): 885-896.
Cita MLA (9a ed.)
Burgard, Caroline, et al. "Change in Total Lesion PSMA (TLP) During [177Lu]Lu-PSMA-617 Radioligand Therapy Predicts Overall Survival in Patients with MCRPC: Monocentric Evaluation of a Prospective Registry." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 3, 2024, pp. 885-896.
Precaución: Estas citas no son 100% exactas.